Quantbot Technologies’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-64,643
Closed -$372K 2260
2022
Q1
$372K Buy
+64,643
New +$580K 0.03% 690
2021
Q4
Sell
-357
Closed -$9K 2021
2021
Q3
$9K Sell
357
-6,466
-95% -$238K ﹤0.01% 1365
2021
Q2
$341K Buy
+6,823
New +$305K 0.03% 642
2021
Q1
Sell
-8,779
Closed -$376K 1855
2020
Q4
$376K Buy
8,779
+6,208
+241% +$236K 0.04% 497
2020
Q3
$104K Buy
2,571
+1,202
+88% +$59.9K 0.01% 717
2020
Q2
$74K Buy
1,369
+400
+41% +$22.9K 0.01% 641
2020
Q1
$50K Buy
+969
New +$52.5K 0.03% 435
2019
Q4
Sell
-1,100
Closed -$60K 1679
2019
Q3
$60K Buy
+1,100
New +$63K 0.01% 937
2019
Q2
Sell
-13,200
Closed -$744K 1507
2019
Q1
$744K Buy
+13,200
New +$787K 0.07% 350
2018
Q2
Sell
-1,799
Closed -$69K 1567
2018
Q1
$69K Buy
+1,799
New +$63K 0.01% 933

Other funds holding TRHC

Quantbot Technologies's TRHC Position: Q2 2022 in Review

Quantbot Technologies sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q2 2022, closing a stake of 64,643 shares — an estimated $372K sold.

Quantbot Technologies first reported a position in TRHC in Q1 2018 and held it in 10 quarters. The position peaked at $744K in Q1 2019. 96 funds tracked by Wall St. Rank hold TRHC as of Q2 2022.

  • Quantbot Technologies reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Quantbot Technologies sold 64,643 Tabula Rasa HealthCare, Inc. Common Stock shares in Q2 2022, an estimated $372K.
  • Quantbot Technologies first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q1 2018 and held it in 10 quarters.
  • Quantbot Technologies's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $744K in Q1 2019.
  • 96 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q2 2022.

Based on Quantbot Technologies's 13F filing for Q2 2022, filed 9 Aug 2022.